COMMON LOW-DENSITY-LIPOPROTEIN RECEPTOR MUTATIONS IN THE FRENCH-CANADIAN POPULATION

被引:272
作者
LEITERSDORF, E
TOBIN, EJ
DAVIGNON, J
HOBBS, HH
机构
[1] UNIV TEXAS, SW MED CTR DALLAS, DEPT INTERNAL MED, 5323 HARRY HINES BLVD, DALLAS, TX 75235 USA
[2] UNIV TEXAS, SW MED CTR DALLAS, DEPT MOLEC GENET, DALLAS, TX 75235 USA
[3] CLIN RES INST MONTREAL, MONTREAL H2W 1R7, QUEBEC, CANADA
关键词
familial hypercholesterolemia; hypercholesterolemia; LDL receptor;
D O I
10.1172/JCI114531
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Familial hypercholesterolemia (FH) has a frequency of 0.2% in most populations of the world. In selected populations such as the Afrikaners in South Africa, the Christian Lebanese, and the French Canadians, the disease is more frequent due to the founder effect. Previous studies demonstrated that a single mutation at the LDL receptor locus, the so-called French Canadian deletion, makes up 60% of the mutant genes responsible for FH in the French Canadian population. In this study, efforts were directed to determine if there were other common LDL receptor mutations in this population. Three missense mutations were identified and each mutation was reproduced and expressed in vitro. Two of the three mutations result in the production of an LDL receptor protein that is not processed to its mature form at a normal rate. Molecular assays were developed to detect the mutations directly, and the LDL receptor genes of 130 French Canandian FH heterozygotes were screened for the presence of the three missense mutations as well as two deletions. LDL receptor mutations were detected in 76% of individuals and 14% had one of the three missense mutations.
引用
收藏
页码:1014 / 1023
页数:10
相关论文
共 40 条
[1]   ORIGIN OF THE BETA-S-GLOBIN GENE IN BLACKS - THE CONTRIBUTION OF RECURRENT MUTATION OR GENE CONVERSION OR BOTH [J].
ANTONARAKIS, SE ;
BOEHM, CD ;
SERJEANT, GR ;
THEISEN, CE ;
DOVER, GJ ;
KAZAZIAN, HH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (03) :853-856
[2]   RESTRICTION SITES CONTAINING CPG SHOW A HIGHER FREQUENCY OF POLYMORPHISM IN HUMAN DNA [J].
BARKER, D ;
SCHAFER, M ;
WHITE, R .
CELL, 1984, 36 (01) :131-138
[3]  
BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923
[4]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[5]   THE CPG DINUCLEOTIDE AND HUMAN GENETIC-DISEASE [J].
COOPER, DN ;
YOUSSOUFIAN, H .
HUMAN GENETICS, 1988, 78 (02) :151-155
[6]  
DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7
[7]  
ESSER V, 1988, J BIOL CHEM, V263, P13282
[8]  
ESSER V, 1988, J BIOL CHEM, V263, P13276
[9]   CONCENTRATED, DIGESTIBLE DNA AFTER HYDROXYLAPATITE CHROMATOGRAPHY WITH CETYLPYRIDINIUM BROMIDE PRECIPITATION [J].
GECK, P ;
NASZ, I .
ANALYTICAL BIOCHEMISTRY, 1983, 135 (02) :264-268
[10]   RECEPTOR-MEDIATED ENDOCYTOSIS - CONCEPTS EMERGING FROM THE LDL RECEPTOR SYSTEM [J].
GOLDSTEIN, JL ;
BROWN, MS ;
ANDERSON, RGW ;
RUSSELL, DW ;
SCHNEIDER, WJ .
ANNUAL REVIEW OF CELL BIOLOGY, 1985, 1 :1-39